PTEN缺失通过极光激酶A诱导小鼠肝外胆管炎-胆管癌连续谱
研究通过Cre-loxp系统在胆管上皮细胞敲除Pten基因,小鼠在出生后1个月即出现硬化性胆管炎样病变,并随年龄进展为浸润性癌;Trp53失活加速进展;Aurka敲除或药物抑制可消除或缓解病变,提示PTEN-AURKA轴在肝外胆管癌发生中起关键作用。
要点
- Pten敲除小鼠肝外胆管上皮和胆周腺体出现硬化性胆管炎样病变,早至出生后1个月胆管扩大扭曲。
- 病变随年龄从低级别异型增生进展为浸润性癌,Trp53失活可加速疾病进展。
- Aurka基因敲除完全消除Pten缺失诱导的肝外胆管病变,药物抑制Aurka可缓解疾病进展。
核心结论
- 肝外胆管细胞和胆周腺体Pten缺失导致依赖Aurka的胆管炎至胆管癌连续谱。
研究设计与样本
- 利用Cre-loxp系统在胆管上皮细胞条件性敲除Pten基因构建小鼠模型,并进行组织学、免疫组化、逆转录PCR、细胞培养和RNA测序分析。
- 进一步使用Trp53和Aurka基因条件性敲除进行机制研究,并测试Aurka抑制剂的疗效。
主要发现
- 小鼠出生后1个月即出现肝外胆管扩大和扭曲,组织学显示上皮增殖增加、炎性细胞浸润和纤维化。
- 病变随年龄从低级别异型增生进展为浸润性癌,Trp53失活可能通过下调衰老加速疾病进展。
- 人和小鼠肝外胆管癌均高表达AURKA,Aurka基因敲除完全消除Pten缺失诱导的肝外胆管病变。
- 药物抑制Aurka可缓解疾病进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The PTEN-AKT pathway is frequently altered in extrahepatic cholangiocarcinoma (eCCA). We aimed to evaluate the role of PTEN in the pathogenesis of eCCA and identify novel therapeutic targets for this disease. METHODS: The Pten gene was genetically deleted using the Cre-loxp system in biliary epithelial cells. The pathologies were evaluated both macroscopically and histologically. The characteristics were further analyzed by immunohistochemistry, reverse-transcription PCR, cell culture, and RNA sequencing. Some features were compared to those in human eCCA samples. Further mechanistic studies utilized the conditional knockout of Trp53 and Aurora kinase A (Aurka) genes. We also tested the effectiveness of an Aurka inhibitor. RESULTS: We observed that genetic deletion of the Pten gene in the extrahepatic biliary epithelium and peri-ductal glands initiated sclerosing cholangitis-like lesions in mice, resulting in enlarged and distorted extrahepatic bile ducts in mice as early as 1 month after birth. Histologically, these lesions exhibited increased epithelial proliferation, inflammatory cell infiltration, and fibrosis. With aging, the lesions progressed from low-grade dysplasia to invasive carcinoma. Trp53 inactivation further accelerated disease progression, potentially by downregulating senescence. Further mechanistic studies showed that both human and mouse eCCA showed high expression of AURKA. Notably, the genetic deletion of Aurka completely eliminated Pten deficiency-induced extrahepatic bile duct lesions. Furthermore, pharmacological inhibition of Aurka alleviated disease progression. CONCLUSIONS: Pten deficiency in extrahepatic cholangiocytes and peribiliary glands led to a cholangitis-to-cholangiocarcinoma continuum that was dependent on Aurka. These findings offer new insights into preventive and therapeutic interventions for extrahepatic CCA. IMPACT AND IMPLICATIONS: The aberrant PTEN-PI3K-AKT signaling pathway is commonly observed in human extrahepatic cholangiocarcinoma (eCCA), a disease with a poor prognosis. In our study, we developed a mouse model mimicking cholangitis to eCCA progression by conditionally deleting the Pten gene via Pdx1-Cre in epithelial cells and peribiliary glands of the extrahepatic biliary duct. The conditional Pten deletion in these cells led to cholangitis, which gradually advanced to dysplasia, ultimately resulting in eCCA. The loss of Pten heightened Akt signaling, cell proliferation, inflammation, fibrosis, DNA damage, epigenetic signaling, epithelial-mesenchymal transition, cell dysplasia, and cellular senescence. Genetic deletion or pharmacological inhibition of Aurka successfully halted disease progression. This model will be valuable for testing novel therapies and unraveling the mechanisms of eCCA tumorigenesis.
引用
- Yang Y, Wang J, Wan J, et al. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. J Hepatol. 2024. PMID: 38428643. doi:10.1016/j.jhep.2024.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。